|
Edmon R. Jennings has served as a director since May 2001. Since July 2003 Mr. Jennings has served as President and CEO of Angiogenix Inc. a biopharmaceutical company. From February 2000 to June 2003 Mr. Jennings was Chief Commercialization Officer at Pain Therapeutics Inc. a medical research and development company. From 1985 to 2000 Mr. Jennings held senior management positions at Genentech Inc. including Vice President of Corporate Development Vice President of Sales and Marketing and Vice President of Sales. Prior to Genentech Mr. Jennings held positions for 12 years with Bristol-Myers Oncology and Bristol Laboratories both of which were divisions of Bristol-Myers (now Bristol-Myers Squibb) a pharmaceutical company. Mr. Jennings received his BA in liberal arts from the University of Michigan at Ann Arbor. | 